226 related articles for article (PubMed ID: 19293613)
21. Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
Hattinger CM; Michelacci F; Sella F; Magagnoli G; Benini S; Gambarotti M; Palmerini E; Picci P; Serra M; Ferrari S
Histopathology; 2015 Sep; 67(3):338-47. PubMed ID: 25600168
[TBL] [Abstract][Full Text] [Related]
22. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
23. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
25. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
27. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
28. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
29. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
[TBL] [Abstract][Full Text] [Related]
30. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
32. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
[TBL] [Abstract][Full Text] [Related]
33. Src nuclear localization and its prognostic relevance in human osteosarcoma.
Urciuoli E; Coletta I; Rizzuto E; De Vito R; Petrini S; D'Oria V; Pezzullo M; Milano GM; Cozza R; Locatelli F; Peruzzi B
J Cell Physiol; 2018 Feb; 233(2):1658-1670. PubMed ID: 28671269
[TBL] [Abstract][Full Text] [Related]
34. Osteosarcoma of the pelvis: outcome analysis of surgical treatment.
Fuchs B; Hoekzema N; Larson DR; Inwards CY; Sim FH
Clin Orthop Relat Res; 2009 Feb; 467(2):510-8. PubMed ID: 18855090
[TBL] [Abstract][Full Text] [Related]
35. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
36. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.
Ozaki T; Flege S; Kevric M; Lindner N; Maas R; Delling G; Schwarz R; von Hochstetter AR; Salzer-Kuntschik M; Berdel WE; Jürgens H; Exner GU; Reichardt P; Mayer-Steinacker R; Ewerbeck V; Kotz R; Winkelmann W; Bielack SS
J Clin Oncol; 2003 Jan; 21(2):334-41. PubMed ID: 12525527
[TBL] [Abstract][Full Text] [Related]
38. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
39. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
40. [Results of the treatment of pediatric osteosarcoma in the Hungarian population].
Hegyi M; Félné Semsei A; Jakab Z; Antal I; Kiss J; Szendrõi M; Csóka M; Kovács G
Magy Onkol; 2012 Mar; 56(1):30-7. PubMed ID: 22403760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
